MG
PIII icon

Michael Gelband’s P3 Health Partners PIII Stock Holding History

Michael Gelband’s Portfolio PIII Stock Details PIII Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-270
Closed -$20K – 1923
2023
Q3 		$20K Buy
+270
New +$28K ﹤0.01% 1624
2022
Q2 		– Sell
-1,278
Closed -$500K – 2332
2022
Q1 		$500K Buy
+1,278
New +$383K 0.01% 1515

Other funds holding PIII

Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EL
EMFO LLC Weston, Florida $112M AUM 18.79% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
HF
HRT Financial New York $54.8B AUM 81.03% 1-Year Est. Return

Michael Gelband's PIII Position: Q4 2023 in Review

Michael Gelband sold out of P3 Health Partners (PIII) in Q4 2023, closing a stake of 270 shares — an estimated $20K sold.

Michael Gelband first reported a position in PIII in Q1 2022 and held it in 2 quarters. The position peaked at $500K in Q1 2022. 66 funds tracked by Wall St. Rank hold PIII as of Q4 2023.

  • Michael Gelband reported no remaining P3 Health Partners position as of Q4 2023 after selling out during the quarter.
  • Michael Gelband sold 270 P3 Health Partners shares in Q4 2023, an estimated $20K.
  • Michael Gelband first reported a position in P3 Health Partners in Q1 2022 and held it in 2 quarters.
  • Michael Gelband's P3 Health Partners position peaked at $500K in Q1 2022.
  • 66 funds tracked by Wall St. Rank held P3 Health Partners as of Q4 2023.

Based on ExodusPoint Capital Management's 13F filing for Q4 2023, filed 14 Feb 2024.